Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation

被引:148
作者
Diken, M. [1 ]
Kreiter, S. [1 ]
Selmi, A. [1 ]
Britten, C. M. [2 ,3 ]
Huber, C. [3 ]
Tuereci, O. [4 ]
Sahin, U. [1 ,2 ,3 ]
机构
[1] Inst Translat Oncol & Immunol TRON, D-55131 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Div Translat & Expt Oncol, Dept Internal Med 3, Mainz, Germany
[3] BioNTech AG, Ribol, Mainz, Germany
[4] Ganymed Pharmaceut AG, Mainz, Germany
关键词
vaccination; dendritic cells; RNA; macropinocytosis; MESSENGER-RNA; IN-VITRO; DIRECT-INJECTION; PLASMID DNA; ANTIGEN; RESPONSES; RECEPTOR; TRIAL; ENDOCYTOSIS; MECHANISMS;
D O I
10.1038/gt.2011.17
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Even though it is known for more than one decade that antigen-encoding RNA can deliver antigenic information to induce antigen-specific immunity against cancer, the nature and mechanism of RNA uptake have remained enigmatic. In this study, we investigated the pharmacokinetics of naked RNA administered into the lymph node. We observed that RNA is rapidly and selectively uptaken by lymph node dendritic cells (DCs). Furthermore, in vitro and in vivo studies revealed that the efficient internalization of RNA by human and murine DCs is primarily driven by macropinocytosis. Selective inhibition of macropinocytosis by compounds or as a consequence of DC maturation abrogated RNA internalization and delivery of encoded antigens. Our findings imply that bioavailability of recombinant RNA vaccines in vivo highly depends on the density and the maturation stage of DCs at the administration site and are of importance for the design of RNA-based clinical immunotherapy protocols. Gene Therapy (2011) 18, 702-708; doi:10.1038/gt.2011.17; published online 3 March 2011
引用
收藏
页码:702 / 708
页数:7
相关论文
共 36 条
[1]  
ANDREESEN R, 1990, CANCER RES, V50, P7450
[2]   Phosphoinositide-3-kinase-independent contractile activities associated with Fcγ-receptor-mediated phagocytosis and macropinocytosis in macrophages [J].
Araki, N ;
Hatae, T ;
Furukawa, A ;
Swanson, JA .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :247-257
[3]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[4]   Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J].
Boczkowski, D ;
Nair, SK ;
Snyder, D ;
Gilboa, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :465-472
[5]   Presentation of exogenous protein antigens on major histocompatability complex class I molecules by dendritic cells: Pathway of presentation and regulation by cytokines [J].
Brossart, P ;
Bevan, MJ .
BLOOD, 1997, 90 (04) :1594-1599
[6]   Endocytosis mechanisms and the cell biology of antigen presentation [J].
Burgdorf, Sven ;
Kurts, Christian .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (01) :89-95
[7]   Protein Transduction Revisited: Novel Insights Into the Mechanism Underlying Intracellular Delivery of Proteins [J].
Edenhofer, Frank .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (34) :3628-3636
[8]   Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity [J].
Fotin-Mleczek, Mariola ;
Duchardt, Katharina M. ;
Lorenz, Christina ;
Pfeiffer, Regina ;
Ojkic-Zrna, Sanja ;
Probst, Jochen ;
Kallen, Karl-Josef .
JOURNAL OF IMMUNOTHERAPY, 2011, 34 (01) :1-15
[9]   Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA [J].
Granstein, RD ;
Ding, WH ;
Ozawa, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (04) :632-636
[10]   Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors [J].
Heiser, A ;
Coleman, D ;
Dannull, J ;
Yancey, D ;
Maurice, MA ;
Lallas, CD ;
Dahm, P ;
Niedzwiecki, D ;
Gilboa, E ;
Vieweg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :409-417